# Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients

> **NCT00868023** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 69 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** CHF 1535 Next DPI
- **DRUG:** Foster BDP/Formoterol
- **DRUG:** CHF 1535 Next DPI
- **DRUG:** Foster BDP/Formoterol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00868023
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-07
- **Final completion:** 2009-10
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868023, "Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00868023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*